Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings

Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2022. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed December 2022

Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. 2021. Available from: https://www.samhsa.gov/data/. Accessed December 2022

Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health. 2020. Available from: https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR090120.htm#:~:text=Among%20adults%20aged%2018%20or,both%20SMI%20and%20an%20SUD. Accessed December 2022

American Hospital Association (AHA). Fentanyl and the opioid epidemic. 2022. Available from: https://www.aha.org/education-events/fentanyl-and-evolution-opioid-epidemic. Accessed December 2022

Marlatt GA, Larimer ME, Witkiewitz K, editors. HR: Pragmatic strategies for managing high-risk behaviors. Guilford Press; 2011 Dec 1. Accessed December 2022

Harm Reduction International (HRI). What is harm reduction?. 2022. Available from: https://hri.global/what-is-harm-reduction/

7 Marlatt, G. A. HR: Come as you are. Addictive Behaviors, 21, 779-788. 1996.

Article  CAS  PubMed  Google Scholar 

Hawk M, Coulter RW, Egan JE, Fisk S, Reuel Friedman M, Tula M, Kinsky S. Harm reduction principles for healthcare settings. Harm reduction journal. 2017 Dec;14(1):1-9.

Kapadia SN, Griffin JL, Waldman J, Ziebarth NR, Schackman BR, Behrends CN. A harm reduction approach to treating opioid use disorder in an independent primary care practice: a qualitative study. Journal of general internal medicine. 2021 Jul;36(7):1898-905.

Jakubowski A, Fox A. Defining low-threshold buprenorphine treatment. Journal of addiction medicine. 2020 Mar;14(2):95.

Yeo EJ, Kralles H, Sternberg D, McCullough D, Nadanasabesan A, Mayo R, Akselrod H, Catalanotti J. Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, DC. Harm Reduction Journal. 2021 Dec;18(1):1-7.

Substance Abuse and Mental Health Services Administration (SAMHSA). SAMHSA announces unprecedented $30 million harm reduction grant funding opportunity to help address the nation’s substance use and overdose epidemic. 2021. Available from: https://www.samhsa.gov/newsroom/press-announcements/202112081000. Accessed December 2022

National Academy of Medicine. Stigma of Addiction Summit: lessons learned and priorities for action. 2022 Jan 31. Available from: https://nam.edu/programs/action-collaborative-on-countering-the-u-s-opioid-epidemic/stigma-summit-proceedings/. Accessed December 2022

Heller D, McCoy K, Cunningham C. An invisible barrier to integrating HIV primary care with harm reduction services: philosophical clashes between the harm reduction and medical models. Public Health Reports. 2004 Jan;119(1):32-9.

Hunniford VT, Grudniewicz A, Fergusson DA, Grigor E, Lansdell C, Lalu MM, Canadian Critical Care Translational Biology Group. Multicenter preclinical studies as an innovative method to enhance translation: a systematic review of published studies. BioRxiv. 2019 Jan 1:591289.

Dorr H, Towney C. Integrating substance use disorder treatment and primary care. 2017. National Academy for State Health Policy. 2017. Available from: https://www.nashp.org/wp-content/uploads/2017/02/Primary-Care-Integration-Brief.pdf. Accessed December 2022

Saitz R, Daaleman TP. Now is the time to address substance use disorders in primary care. The Annals of Family Medicine. 2017 Jul 1;15(4):306-8.

Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International journal for quality in health care. 2007 Dec 1;19(6):349-57.

Consolidated Framework for Implementation Research (CFIR). Constructs. 2022. Available from: https://cfirguide.org/constructs/. Accessed December 2022

20 Birken SA, Powell BJ, Shea CM, Haines ER, Alexis Kirk M, Leeman J, et al. Criteria for selecting implementation science theories and frameworks: results from an international survey. Implement Sci. 2017;12:124. https://doi.org/https://doi.org/10.1186/s13012-017-0656-y.

Article  PubMed  PubMed Central  Google Scholar 

21 Wodak A, Maher L. The effectiveness of harm reduction in preventing HIV among injecting drug users. N S W Public Health Bull. 2010;21:69–73.

Article  PubMed  Google Scholar 

McLellan AT, Starrels JL, Tai B, Gordon AJ, Brown R, Ghitza U, Gourevitch M, Stein J, Oros M, Horton T, Lindblad R. Can substance use disorders be managed using the chronic care model? Review and recommendations from a NIDA consensus group. Public health reviews. 2013 Dec;35(2):1-4.

Busch AB, Sugarman DE, Horvitz LE, Greenfield SF. Telemedicine for treating mental health and substance use disorders: reflections since the pandemic. Neuropsychopharmacology. 2021 May;46(6):1068-70.

Knickman J, Krishnan KR, Pincus H, Blanco C, Blazer D, Coye M, Krystal J, Rauch S, Simon G, Vitiello B. Improving access to effective care for people who have mental health and substance use disorders. Washington, DC: National Academy of Medicine. 2016 Sep 19.

Hyatt AS, Tepper MC, O’Brien CJ. Recognizing and seizing the opportunities that value-based payment models offer behavioral health care. Psychiatric Services. 2021 Jun;72(6):732-5.

Center for Health Care Strategies (CHCS). Behavioral health provider participation in Medicaid value-based payment models: an environmental scan and policy considerations. Washington, DC: Center for Health Care Strategies; 2019.

New York State Office of Addiction Services and Supports (OASAS.). Harm reduction. 2023. Available from: https://oasas.ny.gov/harm-reduction. Accessed December 2022

Schreiber M, Richards AC, Moody-Williams J, Fleischer LA. The CMS national quality strategy: a person-centered approach to improving quality. Centers for Medicare and Medicaid Services. 2022 Jun 6. Available from: https://www.cms.gov/blog/cms-national-quality-strategy-person-centered-approach-improving-quality. Accessed December 2022

U.S Department of Health and Human Services (U.S DHHS). Overdose prevention strategy. 2022. Available from: https://www.hhs.gov/overdose-prevention/. Accessed December 2022

留言 (0)

沒有登入
gif